Regeneron Pharmaceuticals
REGN
#286
Rank
โ‚น6.952 T
Marketcap
โ‚น65,596
Share price
4.86%
Change (1 day)
-0.30%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น244.37 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is โ‚น244.37 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น232.00 B3.11%
2023-12-31โ‚น225.01 B0.66%
2022-12-31โ‚น223.54 B11.25%
2021-12-31โ‚น200.94 B1.92%
2020-12-31โ‚น197.14 B287.25%
2019-12-31โ‚น50.90 B2.76%
2018-12-31โ‚น49.54 B10.29%
2017-12-31โ‚น44.91 B37.39%
2016-12-31โ‚น32.69 B35.56%
2015-12-31โ‚น24.11 B-16.86%
2014-12-31โ‚น29.00 B-6.94%
2013-12-31โ‚น31.17 B24.49%
2012-12-31โ‚น25.04 B8.68%
2011-12-31โ‚น23.03 B221.29%
2010-12-31โ‚น7.17 B41.76%
2009-12-31โ‚น5.05 B1966.47%
2008-12-31โ‚น0.24 B-96.88%
2007-12-31โ‚น7.84 B-11.39%
2006-12-31โ‚น8.85 B-1.58%
2005-12-31โ‚น9.00 B3.91%
2004-12-31โ‚น8.66 B-11.03%
2003-12-31โ‚น9.73 B1.43%
2002-12-31โ‚น9.59 B-0.83%
2001-12-31โ‚น9.67 B7634.6%
2000-12-31โ‚น0.12 B-29.8%
1999-12-31โ‚น0.17 B-0.19%
1998-12-31โ‚น0.17 B-18.85%
1997-12-31โ‚น0.22 B-29.63%
1996-12-31โ‚น0.31 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
โ‚น4.930 T 1,917.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น118.18 B-51.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น595.26 B 143.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น4.136 T 1,592.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น2.892 T 1,083.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น2.306 T 843.68%๐Ÿ‡ซ๐Ÿ‡ท France